Alnylam/Isis’s Regulus to Go Public – Analyst Blog
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently announced the filing of a registration statement with the US Securities and Exchange Commission (SEC). The...
Read More

